HealthQuill Vaccines
Novovax Inc., will soon start enrollment for end-stage trials of its Covid-19-Influenza vaccine and stand-alone influenza jab following a nod from the US drug regulator.
Drugs Health Pharma

US drug regulator removes clinical hold on Novavax’s vaccines

Novovax Inc., will soon start enrollment for end-stage trials of its Covid-19-Influenza vaccine and stand-alone influenza jab following a nod from the US.

Read More
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in people 18-59 years.
Drugs Health Pharma

US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine

The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.

Read More
Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally, according to a World Health Organization report.
Drugs Health Pharma

Vaccines against pathogens can cut global antibiotic usage by 22%

Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,.

Read More
The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year to 16, government data showed.
Drugs Health Medical

California state confirms two cases of bird flu, US total stands at 16 now

The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year.

Read More
Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.
Drugs Health Medical

Harvard develops drug-free nasal spray to block viruses, bacteria

Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.

Read More
Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.
Drugs Health Pharma

Emergent gets US drug regulator’s nod to use its smallpox vaccine for mpox

Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.

Read More
The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely matching variants circulating in humans, according to a study.
Drugs Health Pharma

Backyard species in US gets Covid-19 through human-to-animal spread

The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely.

Read More
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative unveiled in October last year, when sales of its Covid-19 vaccine plummeted.
Drugs Health Pharma

Pfizer Inc. unveils a new $1.5 billion plan to cut costs as vaccine sales fall

Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative.

Read More
Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda Gates Foundation to fund its production of needle-free vaccines.
Health Medical Pharma

Micron gets $23.6m Gates Foundation grant to make needle-free vaccines

HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.

Read More
Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a company statement.
Drugs Health Medical Pharma

Pfizer to raise $31 billion in long-term debt for Seagen acquisition

HQ Team May 18, 2023: Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a.

Read More